Helicobacter pylori treatment knowledge, access and barriers: A cross‐sectional study.
- Published in:
- Helicobacter, 2023, v. 28, n. 2, p. 1, doi. 10.1111/hel.12954
- By:
- Publication type:
- Article
Works matching IS 10834389 AND DT 2023 AND VI 28 AND IP 2
Results: 12
1
2
Regulatory B cells (Bregs) in Helicobacter pylori chronic infection.
- Published in:
- Helicobacter, 2023, v. 28, n. 2, p. 1, doi. 10.1111/hel.12951
- By:
- Publication type:
- Article
3
Cardia and non‐cardia gastric cancer risk associated with Helicobacter pylori in East Asia and the West: A systematic review, meta‐analysis, and estimation of population attributable fraction.
- Published in:
- Helicobacter, 2023, v. 28, n. 2, p. 1, doi. 10.1111/hel.12950
- By:
- Publication type:
- Article
4
Persistent advanced periductal fibrosis is and helicobacter pylori infection in post‐treatment of opisthorchiasis: Correspondence.
- Published in:
- Helicobacter, 2023, v. 28, n. 2, p. 1, doi. 10.1111/hel.12949
- By:
- Publication type:
- Article
5
New regimens as first‐line eradication therapy for Helicobacter pylori infection in patients allergic to penicillin: A randomized controlled trial.
- Published in:
- Helicobacter, 2023, v. 28, n. 2, p. 1, doi. 10.1111/hel.12956
- By:
- Publication type:
- Article
6
DNA starvation/stationary phase protection protein of Helicobacter pylori as a potential immunodominant antigen for infection detection.
- Published in:
- Helicobacter, 2023, v. 28, n. 2, p. 1, doi. 10.1111/hel.12955
- By:
- Publication type:
- Article
7
Network meta‐analysis of different dosages of esomeprazole and rabeprazole for the treatment of Helicobacter pylori.
- Published in:
- Helicobacter, 2023, v. 28, n. 2, p. 1, doi. 10.1111/hel.12948
- By:
- Publication type:
- Article
8
Impact of body size on efficacy of high‐dose dual therapy for Helicobacter pylori eradication.
- Published in:
- Helicobacter, 2023, v. 28, n. 2, p. 1, doi. 10.1111/hel.12953
- By:
- Publication type:
- Article
9
Critical appraisal of international guidelines for the management of Helicobacter pylori infection in case of dyspepsia.
- Published in:
- Helicobacter, 2023, v. 28, n. 2, p. 1, doi. 10.1111/hel.12952
- By:
- Publication type:
- Article
10
Intravenous metronidazole‐, levofloxacin‐containing triple therapy for treating patients with Helicobacter pylori‐related active peptic ulcer complications: A pilot study.
- Published in:
- Helicobacter, 2023, v. 28, n. 2, p. 1, doi. 10.1111/hel.12946
- By:
- Publication type:
- Article
11
Issue Information.
- Published in:
- Helicobacter, 2023, v. 28, n. 2, p. 1, doi. 10.1111/hel.12902
- Publication type:
- Article
12
A real‐world exploratory study on the feasibility of vonoprazan and tetracycline dual therapy for the treatment of Helicobacter pylori infection in special populations with penicillin allergy or failed in previous amoxicillin‐containing therapies
- Published in:
- Helicobacter, 2023, v. 28, n. 2, p. 1, doi. 10.1111/hel.12947
- By:
- Publication type:
- Article